NCT02144948

Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II

Pilot Study to Investigate the Effect of E-coli-nissle as Probiotic Adjuvant to Antidiabetic Standard Care in Patients With Diabetes Mellitus Type II

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: GWT-TUD GmbH · Academic / Other
• Sex: All
• Age: 45 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a pilot study to investigate the effect of e.-coli-nissle as supporting therapy to antidiabetic standard care in patients with diabetes mellitus type II

Conditions

• Diabetes Mellitus Type II

Interventions

Type	Name	Description
DRUG	e.-coli-nissle	1 ml qd for 24 weeks

Timeline

• Start date: 2014-08-01
• Primary completion: 2016-01-01
• Completion: 2016-01-01
• First posted: 2014-05-22
• Last updated: 2017-02-14

Locations

1 site across 1 country: Germany